Metabolic Health
Beyond Weight Loss: Tirzepatide's Inflammation Signal and the Combo Therapy Shift
New meta-analyses suggest the metabolic-drug story is moving past the scale — toward measurable inflammation reduction and stacked cardiorenal protection. Here's what that actually changes for a 40-year-old.